Evidence check: ApoB in the context of weight loss

ApoB (Apolipoprotein B) is a core component of atherogenic lipoproteins and is considered a more accurate cardiovascular risk marker than LDL cholesterol. In the context of weight loss, general evidence indicates that moderate weight reduction (5–10%) can significantly lower ApoB, especially when achieved through calorie-restricted, Mediterranean, or fat-modified diets. However, the provided context sources contain no specific studies or data directly linking weight loss to ApoB changes. Therefore, this statement is based on general medical knowledge rather than the information supplied here. The evidence is rated as 'human-moderate' because the association between weight loss and improved lipid profiles is well-established, but the specific ApoB measurement in this context is not detailed. Caveat: Individual genetic factors (e.g., APOE variants) may modulate ApoB response to weight loss, which is not addressed in the sources. Safety note: Rapid or extreme weight loss can promote gallstone formation and should be medically supervised.